Maternal intrapartum antibiotic treatment continues to exert a bactericidal effect on the umbilical cord and peripheral venous blood of newborn infants. (2nd August 2017)

• Record Type: Journal Article
• Authors: Hershkovich–Shporen, C; Bardenstein, R; Blickstein, I; Shinwell, E S; Flidel‐Rimon, O
• Is Part Of: Acta pædiatrica. Volume 106:Number 11(2017)
• Page Start: 1767
• Page End: 1771
• Publication Date: 2017-08-02
• Subjects: Bactericidal effect -- Early onset sepsis -- Escherichia coli -- Group B Streptococcus -- Intrapartum antibiotic treatment; Pediatrics -- Periodicals; Pediatrics; 618.92
• DOI: 10.1111/apa.13982
• Languages: English
• ISSNs: 0803-5253

Abstract

Abstract: Aim: It is unclear whether maternal intrapartum antibiotic treatment (IAT) continues to exert a bactericidal effect on common pathogens in neonates. We studied the in vitro bactericidal effect of IAT on the cord and peripheral venous blood of newborn infants. Methods: Umbilical cord and peripheral venous blood from newborn infants born at Kaplan Medical Center, Israel, from April to October 2014 were studied for serum bactericidal titres against Group B Streptococcus ( GBS ) and Escherichia coli ( E. coli ) strains. We studied 60 samples of umbilical cord blood and 18 samples of peripheral venous blood from 60 newborn infants whose mothers received IAT. The controls were 10 samples of cord blood from mothers without IAT. Results: Cord blood exerted a bactericidal effect against 98% of GBS isolates but only 8% of E.coli isolates. Peripheral blood exerted a bactericidal effect against GBS in 94% of cases, but not against E. coli . No bactericidal effect was seen in the blood from the controls. Conclusion: We found a continued bactericidal effect of umbilical cord blood and neonatal peripheral blood from newborn infants of IAT‐treated mothers, mainly against GBS, but rarely against E. Coli . These findings may assist clinicians treating at‐risk infants exposed to IAT.